Compare Amylx Pharmaceuticals Inc (AMLX) vs Chipotle Mexican Grill, Inc. (CMG) Price & Performance

Amylx Pharmaceuticals IncTrade

Chipotle Mexican Grill, Inc.Trade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Chipotle Mexican Grill, Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Chipotle Mexican Grill, Inc. trades at $32.3 (market cap $40.49B). The key difference: Chipotle Mexican Grill, Inc. is far larger — about 15.3× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Chipotle Mexican Grill, Inc. nearer its low. Which is the better fit depends on your goals.

	AMLX	CMG
Market Cap	$2.64B	$40.49B
Sector	Health	Consumer Cyclical
52-Week High	$24.19	$44.04
52-Week Low	$7.82	$28.17
Enterprise Value	$2.39B	$45.24B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amylx Pharmaceuticals Inc

AMLX trades at $22.82, down 5.66% on the day, with a bullish technical signal from moving averages and key support at $22. The company reported a net loss of -$144.74M for 2025, with negative ROE and ROA, but holds a $250.8M cash runway into 2028. The pivotal Phase 3 LUCIDITY trial for avexitide is set for a late August/early September 2026 readout, a key near-term catalyst.

Analyst consensus is strongly bullish with a $30.00 price target, though recent earnings misses and negative cash flow from operations in 2026 pose risks. The stock's outlook hinges on successful clinical trial results and the subsequent regulatory pathway for its lead endocrine asset.

Chipotle Mexican Grill, Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMLX

Amylyx shifts focus to endocrine drug avexitide with strong cash runway into 2028 and key trial results in 2026Seeking Alpha · 4 days agoBullish View details →

CMG

Chipotle shares drop over 12% amid margin pressure and cautious outlook despite growth plans.24/7 Wall Street · 1 day agoBullish Chipotle IQ trivia returns with $1M in prizes, new card game, and free burritos for a year sweepstakesPRNewsWire · 1 day agoBullish Michael Burry doubts Berkshire Hathaway's new leadership under Greg Abel, Meta faces $1.4T US penalties, Taylor Farms recalls jalapeño products.Seeking Alpha · 2 days agoBearish View details →

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

About Chipotle Mexican Grill, Inc.

Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.